Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 5, 2014, Pages 1650-1659

  Mewhort, Holly E M ^a   Turnbull, Jeannine D ^a   Meijndert, H Christopher ^a   Ngu, Janet M C ^a   Fedak, Paul W M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMATERIAL PATCH; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPICARDIAL INFARCT REPAIR; EXTRACELLULAR MATRIX; FIBROSIS; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART SURGERY; HISTOPATHOLOGY; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMPLANT; INFLAMMATION; MALE; NONHUMAN; POSTISCHEMIC CARDIAC REMODELING; PRIORITY JOURNAL; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARDIAC SURGICAL PROCEDURES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, INBRED F344; RECOVERY OF FUNCTION; REGENERATION; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84899984853     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.08.005     Document Type: Article

References (37)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and W.B. Borden et al. Executive summary: heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 143 152
2. Canadian Council on Animal Care. Guide for the care and use of experimental animals. Available at: http://www.ccac.ca/Documents/Standards/ Guidelines/Experimental-Animals-Vol1.pdf. Accessed August 30, 2013.
3. National Academy of Sciences. Guide for the Care and Use of Laboratory Animals 1996 The National Academy Press Washington, DC
4. P.W.M. Fedak, L. Bai, J. Turnbull, J. Ngu, K. Narine, and H.J. Duff Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism Circ Heart Fail 5 2012 349 356
5. V.C. Oliveira, R.C.V. Carrara, D.L.C. Simoes, F.P. Saggioro, C.G. Carlotti, and D.T. Covas et al. Sudan Black B treatment reduces autofluorescence and improves resolution of in situ hybridization specific fluorescent signals of brain sections Histol Histopathol 25 2010 1017 1024
6. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D.A. Kass Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats Nat Protoc 3 2008 1422 1434
7. N. Ohno, P.W.M. Fedak, R.D. Weisel, D.A.G. Mickle, T. Fujii, and K. Li R- Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function J Thorac Cardiovasc Surg 126 2003 1537 1548
8. J.E. Murphy-Ullrich The de-Adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 107 2001 785 790
9. R.D. Brown, S.K. Ambler, and M.D. Mitchell The cardiac fibroblast: therapeutic target in myocardial remodeling and failure Annu Rev Pharmacol Toxicol 45 2005 657 687
10. S. Rosenkranz TGF-beta1 and angiotensin networking in cardiac remodeling Cardiovasc Res 63 2004 423 432
11. H.K. Graham, M. Horn, and A.W. Trafford Extracellular matrix profiles in the progression to heart failure Acta Physiologica 194 2008 3 21
12. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodeling Lancet 367 2006 356 367
13. N.G. Frangogiannis Matricellular proteins in cardiac adaptation and disease Physiol Rev 92 2012 635 688
14. I.M. Khouw, P.B. van Wachem, J.A. Plantinga, Z. Vujaskovic, M.J. Wissink, and L.F. de Leij et al. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro Biomaterials 20 1999 1815 1822
15. H.C. Ott, T.S. Matthiesen, S.-K. Goh, L.D. Black, S.M. Kren, and T.I. Netoff et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart Nat Med 14 2008 213 221
16. P.W.M. Fedak Cardiac progenitor cell sheet regenerates myocardium and renews hope for translation Cardiovasc Res 87 2010 8 9
17. P.W.M. Fedak, P.E. Szmitko, R.D. Weisel, S.M. Altamentova, N. Nili, and N. Ohno et al. Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism J Thorac Cardiovasc Surg 130 2005 1430 1439
18. S. Fazel, L. Chen, R.D. Weisel, D. Angoulvant, C. Seneviratne, and A. Fazel et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor J Thorac Cardiovasc Surg 130 2005 1310
19. S. Badylak, D. Freytes, and T. Gilbert Extracellular matrix as a biological scaffold material: structure and function Acta Biomaterialia 5 2009 1 13
20. K.A. Robinson, J. Li, M. Mathison, A. Redkar, J. Cui, and N.A.F. Chronos et al. Extracellular matrix scaffold for cardiac repair Circulation 112 2005 I135 I143
21. Y. Zhang, D. Frimberger, E.Y. Cheng, H.-K. Lin, and B.P. Kropp Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model BJU Int 98 2006 1100 1105
22. B. Brown, K. Lindberg, J. Reing, D.B. Stolz, and S.F. Badylak The basement membrane component of biologic scaffolds derived from extracellular matrix Tissue Eng 12 2006 519 526
23. C.A. McDevitt, G.M. Wildey, and R.M. Cutrone Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa J Biomed Mater Res A 67 2003 637 640
24. S.L. Voytik-Harbin, A.O. Brightman, M.R. Kraine, B. Waisner, and S.F. Badylak Identification of extractable growth factors from small intestinal submucosa J Cell Biochem 67 1997 478 491
25. J.P. Hodde, D.M.J. Ernst, and M.C. Hiles An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix J Wound Care 14 2005 23 25
26. K.A. Daly, A.M. Stewart-Akers, H. Hara, M. Ezzelarab, C. Long, and K. Cordero et al. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model Tissue Eng Part A 15 2009 3877 3888
27. E.N. Mostow, G.D. Haraway, M. Dalsing, J.P. Hodde, D. King OASIS Venus Ulcer Study Group Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial J Vasc Surg 41 2005 837 843
28. A. Quarti, S. Nardone, M. Colaneri, G. Santoro, and M. Pozzi Preliminary experience in the use of an extracellular matrix to repair congenital heart diseases Interact Cardiovasc Thorac Surg 13 2011 569 572
29. H. Suma, and A.C. Anyanwu Current status of surgical ventricular restoration for ischemic cardiomyopathy Semin Thorac Cardiovasc Surg 24 2012 294 301
30. M.R. Costanzo, R.J. Ivanhoe, A. Kao, I.S. Anand, A. Bank, and J. Boehmer et al. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial J Card Fail 18 2012 446 458
31. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, and C. Held et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
32. T.W. Gilbert, A. Nieponice, A.R. Spievack, J. Holcomb, S. Gilbert, and S.F. Badylak Repair of the thoracic wall with an extracellular matrix scaffold in a canine model J Surg Res 147 2008 61 67
33. K. Kang, L. Sun, Y. Xiao, S.-H. Li, J. Wu, and J. Guo et al. Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration J Am Coll Cardiol 60 2012 2237 2249
34. A.J. Beattie, T.W. Gilbert, J.P. Guyot, A.J. Yates, and S.F. Badylak Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds Tissue Eng Part A 15 2009 1119 1125
35. P.W.M. Fedak, S. Verma, R.D. Weisel, and R-K. Li Cardiac remodeling and failure from molecules to man (Part II) Cardiovasc Pathol 14 2005 49 60
36. P.W.M. Fedak Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart Semin Thorac Cardiovasc Surg 20 2008 87 93
37. T. Kempf, A. Zarbock, D. Vestweber, and K.C. Wollert Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing J Mol Med 90 2012 361 369